These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 23200771)

  • 1. Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.
    Maguire J; Salpekar JA
    Epilepsy Behav; 2013 Mar; 26(3):352-62. PubMed ID: 23200771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.
    Basu T; Maguire J; Salpekar JA
    Neurosci Lett; 2021 Feb; 746():135618. PubMed ID: 33429002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.
    Ginsberg AB; Pecoraro NC; Warne JP; Horneman HF; Dallman MF
    Stress; 2010 May; 13(3):248-57. PubMed ID: 20392196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders.
    Martocchia A; Curto M; Toussan L; Stefanelli M; Falaschi P
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):196-204. PubMed ID: 21834781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epilepsy and hormones].
    Motta E
    Neurol Neurochir Pol; 2000; 34 Suppl 1():31-6. PubMed ID: 10768143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenocortical axis dysfunction in epilepsy.
    Wulsin AC; Solomon MB; Privitera MD; Danzer SC; Herman JP
    Physiol Behav; 2016 Nov; 166():22-31. PubMed ID: 27195458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis.
    Rao RT; Scherholz ML; Androulakis IP
    Chronobiol Int; 2018 Nov; 35(12):1619-1636. PubMed ID: 30059634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive modeling of the hypothalamic-pituitary-adrenal (HPA) axis response to acute and chronic stress.
    Marković VM; Čupić Ž; Vukojević V; Kolar-Anić L
    Endocr J; 2011; 58(10):889-904. PubMed ID: 21852742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steroid therapy and adrenal function].
    Cota D; Ceroni L; Pasquali R
    Recenti Prog Med; 2000 Nov; 91(11):594-600. PubMed ID: 11125954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hypothalamic-Pituitary-Adrenal Axis and Anesthetics: A Review.
    Besnier E; Clavier T; Compere V
    Anesth Analg; 2017 Apr; 124(4):1181-1189. PubMed ID: 27984246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus.
    Weiser MJ; Handa RJ
    Neuroscience; 2009 Mar; 159(2):883-95. PubMed ID: 19166915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.
    Harris HJ; Kotelevtsev Y; Mullins JJ; Seckl JR; Holmes MC
    Endocrinology; 2001 Jan; 142(1):114-20. PubMed ID: 11145573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the HPA axis: where and when do sex differences manifest?
    Panagiotakopoulos L; Neigh GN
    Front Neuroendocrinol; 2014 Aug; 35(3):285-302. PubMed ID: 24631756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability.
    Gupta S; Aslakson E; Gurbaxani BM; Vernon SD
    Theor Biol Med Model; 2007 Feb; 4():8. PubMed ID: 17300722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of the Hypothalamic-Pituitary-Adrenal Axis in a Male Rat Chronic Stress Model.
    Franco AJ; Chen C; Scullen T; Zsombok A; Salahudeen AA; Di S; Herman JP; Tasker JG
    Endocrinology; 2016 Jun; 157(6):2346-55. PubMed ID: 27054552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflamed axis: the interaction between stress, hormones, and the expression of inflammatory-related genes within key structures comprising the hypothalamic-pituitary-adrenal axis.
    Hueston CM; Deak T
    Physiol Behav; 2014 Jan; 124():77-91. PubMed ID: 24184413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizure-induced disinhibition of the HPA axis increases seizure susceptibility.
    O'Toole KK; Hooper A; Wakefield S; Maguire J
    Epilepsy Res; 2014 Jan; 108(1):29-43. PubMed ID: 24225328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.